LUMO IMAGING LLC

Medtech · Private

Total Body Photography system with AI-powered software for longitudinal tracking and morphologic analysis of pigmented skin lesions to detect early-stage skin cancers

Grants
$1.7M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$74K
3 awards · Health and Human S
#547 of 4531 in medtech
Patents
1
1 granted · 0 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · STTR Phase I: Dermatologist-level detection of suspicious pigmented skin lesions from high-resolution full-body images$255,999
Federal grantDepartment of Health and Human Services · Phase I · System for documenting and tracking skin lesions$252,388
Federal contractDepartment of Health and Human Services · Nichd - Dermatoscope Attachment Equipment And Software Application For Skin Lesion Temporal Studies.$30,299
Federal grantNational Science Foundation · Phase II · STTR Phase II: Dermatologist-level detection of suspicious pigmented skin lesions from high-resolution full-body images$1,211,573
Federal contractDepartment of Health and Human Services · Nichd - Lumoscan Portable S/w For Cancer Study$22,299
Federal contractDepartment of Health and Human Services · Nichd - Upgrade To Fnirs System For Functional Brain Imaging Studies$21,675
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
544Michael Francis$75K—
545GENERAL OPTICS LLC$75K—
546DesiCorp, Inc.$75K$1.8M
547LUMO IMAGING LLC$74K—
548RHEONIX, INC.$73K$45M
549BIODESIX INC$70K$156M
550LASMED LTD LIABILITY CORP$70K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 1

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.